Tasigna Atherosclerosis Risks Concealed from Doctors, Patients in U.S.: Lawsuit
Plaintiff had to undergo four coronary artery bypass grafts due to Tasigna atherosclerosis risks, the lawsuit states.
Tag Archives: Novartis
-
-
Beovu Injection Caused Retinal Vasculitis and Other Vision Side Effects, Lawsuit Alleges
Plaintiff indicates he suffered vision loss due to the Beovu injection causing inflammation of blood vessels in the retina.
-
Beovu Lawsuit Over Eye Injury Cleared to Move Forward After Judge Rejects Novartis’ Motion to Dismiss
It is the second time in a year a federal judge has rejected Novartis' efforts to have Beovu injection lawsuits dismissed on preemption grounds.
-
Tasigna Lawsuit Moves Forward, After Interlocutory Appeal of Preemption Ruling Denied
A federal judge determined the lawsuit was not barred due to preemption laws, after plaintiff brought evidence suggesting Novartis had new information which could have led to updated label warnings.
-
Tasigna Side Effects Led To Partial Leg Amputation, Lawsuit Claims
Lawsuit claims Novartis purposefully hid risks of narrowing and hardening arteries to increase profits.
-
Beovu Injection Lawsuit Over Retinal Injury, Blindness Cleared To Proceed
-
Wrongful Death Lawsuit Filed Over Tasigna Heart Injury Risk
-
Lawsuit Alleges Tasigna Stroke Side Effects Not Adequately Disclosed By Cancer Drug Makers
-
Tasigna Death Lawsuit Filed Over Fatal Stroke Complications
-
Tasigna Case Study Links Cancer Drug To Increased Risk of Angina from Narrowing, Hardening of Arteries
